Methylergometrine
Vérifier sur isomerdesign
Methylergonovine
Vérifier sur pubchem
Methylergonovine
Vérifier sur drugmap
Methylergometrine
Vérifier sur wiki
Data
InChI: InChI=1S/C20H25N3O2/c1-3-14(11-24)22-20(25)13-7-16-15-5-4-6-17-19(15)12(9-21-17)8-18(16)23(2)10-13/h4-7,9,13-14,18,21,24H,3,8,10-11H2,1-2H3,(H,22,25)
Synonymes: Methergine,NINDS_000357,(8.BETA.)-N-((1S)-1-(HYDROXYMETHYL)PROPYL)-6-METHYL-9,10-DIDEHYDROERGOLINE-8-CARBOXAMIDE,H8D,METHYLERGOMETRINE [WHO-DD],KBioSS_000743,METHYLERGOMETRINE [HSDB],BPBio1_000442, Methylergometrinum [INN-Latin],Methergen,Lysergic acid butanolamide,Ergometrine, methyl-,(8beta)-N-[(1S)-1-(hydroxymethyl)propyl]-6-methyl-9,10-didehydroergoline-8-carboxamide, D-Lysergic acid-dl-hydroxybutylamide-2,D-Lysergic acid-(+)-butanolamide-(2), Metilergometrina [DCIT], ME 277,SDCCGSBI-0050771.P005,IDI1_000357, Methylergonovin,DivK1c_000357,D-lysergic acid 1-butanolamide,CHEMBL1201356, Methylergometrine maleate, Ergotyl,N-(alpha-(Hydroxymethyl)propyl)-D-lysergamide,SCHEMBL78176,Methylergonovine,BSPBio_000527,DSSTox_CID_3283,Ergoline-8-beta-carboxamide, 9,10-didehydro-N-((S)-1-(hydroxymethyl)propyl)-6-methyl-, Methylergometrine (INN),AB00053497_03,BRD-K34685430-050-04-2, Metilergometrinio,NCGC00017258-12, 9,10-Didehydro-N-(alpha-(hydroxymethyl)propyl)-6-methyl-ergoline-8-beta-carboxamide,KBio2_005879,BRD-K34685430-050-06-7, Metilergometrina, Spametrin-M,UNII-W53L6FE61V,Partergin,Methylergonovin, Ryegonovin,METHYLERGOMETRINE [INN],Methylergobasine,D-Lysergic acid-dl-hydroxybutylamide-2,Methylergometrinum, Partergin, Methergine (TN),W53L6FE61V,KBio2_000743,Ergotyl, Metilergometrinio [INN-Spanish], N-(alpha-(Hydroxymethyl)propyl)-D-lysergamide,Methylergobasin, Methergin,ME 277,methylergonovine,NCGC00017258-03,BRD-K34685430-001-01-1,Ergoline-8-carboxamide, 9,10-didehydro-N-(1-(hydroxymethyl)propyl)-6-methyl-, (8beta(S))-,NCGC00017258-08,HSDB 3364, Methylergometrine, Lysergic acid butanolamide,(8beta)-N-[(2S)-1-hydroxybutan-2-yl]-6-methyl-9,10-didehydroergoline-8-carboxamide,(4R,7R)-N-[(2S)-1-hydroxybutan-2-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(15),2,9,12(16),13-pentaene-4-carboxamide,NCGC00017258-04,BSPBio_002023,Tox21_110809,Spectrum3_000502,DSSTox_RID_76957,CAS-113-42-8, 9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-6-methylergoline-8-carboxamide,NCGC00017258-05,Methylergometrinum [INN-Latin],Methergine,KBio1_000357,Methylergometrine (INN),Q424477,CCG-204878,Methylergometrine maleate,Metilergometrinio,Methylergometrin, Methergen,ZINC95619105,Lysergamide, N-((S)-1-(hydroxymethyl)propyl)-,Metilergometrina [DCIT],SBI-0050771.P004, Methylergometrinum,Lopac0_000794,CHEBI:92607,EN300-6481358,N-(1-Hydroxybutan-2-yl)lysergamide,GTPL150,Methylergobrevin,EINECS 204-027-0, D-Lysergic acid-(+)-butanolamide-(2),BDBM50330860, Methylergometrine [INN:BAN],Metilergometrina, Methylergobrevin,Tox21_110809_1, Methylergobasin,DB00353,KBio3_001523,DSSTox_GSID_23283,KBio2_003311, Methylergometrin, Methylergobasine, (8beta)-N-[(1S)-1-(hydroxymethyl)propyl]-6-methyl-9,10-didehydroergoline-8-carboxamide,(6aR,9R)-N-[(2S)-1-hydroxybutan-2-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide,NCGC00024646-02,(4R,7R)-N-[(2S)-1-hydroxybutan-2-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide,113-42-8,9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-6-methylergoline-8-carboxamide, Ergotyl (TN),Ergotyl (TN),SPBio_000546,Spectrum5_001879,D08207,Methylergometrine [INN:BAN],METHYLERGONOVINE [MI],AB00514664,Methylergometrine,Spectrum_000263, Metenarin,BPBio1_000581,METHYLERGONOVINE [VANDF],Metilergometrinio [INN-Spanish],NCGC00024646-03,NCGC00017258-06,Basofortina,Biomol-NT_000154,9,10-Didehydro-N-(alpha-(hydroxymethyl)propyl)-6-methyl-ergoline-8-beta-carboxamide,DTXSID00904978,Prestwick3_000374,Spectrum2_000613
Estimated data
Solubility: -2.603 (log(S) in mol/L prediction using SolTranNet)
Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)
Addictivity Prediction: 58.8% (prediction based on www.mdpi.com)
